|Bid||133.36 x 300|
|Ask||133.69 x 500|
|Day's Range||132.19 - 133.65|
|52 Week Range||109.32 - 137.08|
|PE Ratio (TTM)||22.43|
|Dividend & Yield||3.36 (2.53%)|
|1y Target Est||N/A|
A Los Angeles jury on Monday ordered Johnson & Johnson to pay a record $417 million to a hospitalized woman who claimed in a lawsuit that the talc in the company's iconic baby powder causes ovarian cancer ...
The Latest on a Los Angeles jury ordering Johnson & Johnson to pay $417 million in a case alleging talcum powder causes ovarian cancer (all times local): ___ 12:30 p.m. The attorney for a hospitalized ...
A California jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene. The Los Angeles Superior Court jury's verdict in favor of California resident Eva Echeverria was the largest yet in lawsuits alleging J&J failed to adequately warn consumers about the cancer risks of its talc-based products. "We are grateful for the jury's verdict on this matter and that Eva Echeverria was able to have her day in court," Mark Robinson, her lawyer, said in a statement.